By Denise Baez DG Alerts A prolonged activated partial-thromboplastin time (aPTT) should not be a barrier to the use of anticoagulation therapies in the prevention and treatment of venous thrombosis in patients with coronavirus disease 2019 (COVID-19), according to a study published in The New England Journal of Medicine. “In our study, most patients with […]
Read MoreAUTHORS: Cook-Sather, Scott D. MD et al Anesthesia & Analgesia: March 2020 – Volume 130 – Issue 3 – p 730-739 BACKGROUND: Prophylactic analgesic administration reduces pain behavior after pediatric bilateral myringotomy and pressure equalization tube placement (BMT). We hypothesized that postoperative pain in children treated with intraoperative ketorolac would, among several exposures of interest, […]
Read MoreAUTHORS: Freundlich, Robert E. MD, MS et al Anesthesia & Analgesia: March 2020 – Volume 130 – Issue 3 – p 725-729 BACKGROUND: Although the surgical pause or time-out is a required part of most hospitals’ standard operating procedures, little is known about the quality of execution of the time-out in routine clinical practice. An […]
Read MoreAUTHORS: Shaydenfish, Denys Cand Med et al Anesthesia & Analgesia: March 2020 – Volume 130 – Issue 3 – p 685-695 BACKGROUND: The anticholinesterase neostigmine and the muscarinic inhibitor glycopyrrolate are frequently coadministered for the reversal of neuromuscular blockade. This practice can precipitate severe bradycardia or tachycardia, but whether it affects the incidence of cardiovascular […]
Read MoreAuthors: Qisheng Ou, Ph.D. et al Anesthesia Patient Safety Foundation Disclaimer: We aim to present letters from our readership that may generate further discussion on managing patients with COVID-19. Given the novelty of COVID-19, best-available clinical evidence is limited and supported from anecdotal reports from China, South Korea, Italy and other sites, and from studies of […]
Read More